Found: 31
Select item for more details and to access through your institution.
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1539, doi. 10.1007/s12094-024-03383-x
- By:
- Publication type:
- Article
The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 2, p. 417, doi. 10.1007/s12094-022-02953-1
- By:
- Publication type:
- Article
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Bone loss induced by cancer treatments in breast and prostate cancer patients.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2090, doi. 10.1007/s12094-022-02872-1
- By:
- Publication type:
- Article
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 9, p. 1744, doi. 10.1007/s12094-022-02824-9
- By:
- Publication type:
- Article
SEOM clinical guidelines 2020.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Functions and workload of medical oncologists in Spain.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 6, p. 423, doi. 10.1007/s12094-012-0819-x
- By:
- Publication type:
- Article
Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 2, p. 125, doi. 10.1007/s12094-012-0771-9
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of metastatic breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 11, p. 719, doi. 10.1007/s12094-010-0585-6
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of early breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 11, p. 711, doi. 10.1007/s12094-010-0584-7
- By:
- Publication type:
- Article
Current controversies in the management of breast cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 4, p. 278, doi. 10.1007/s12094-010-0504-x
- By:
- Publication type:
- Article
Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 2, p. 142, doi. 10.1007/S12094-010-0479-7
- By:
- Publication type:
- Article
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 7, p. 446, doi. 10.1007/s12094-009-0383-1
- By:
- Publication type:
- Article
Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 1, p. 41, doi. 10.1007/s12094-009-0309-y
- By:
- Publication type:
- Article
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 9, p. 552, doi. 10.1007/s12094-008-0250-y
- By:
- Publication type:
- Article
Recurrent pericardial effusion as initial manifestation of primary diffuse pericardial malignant mesothelioma.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 9, p. 694, doi. 10.1007/s12094-006-0042-8
- By:
- Publication type:
- Article
Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy.
- Published in:
- Clinical & Translational Oncology, 2004, v. 6, n. 1, p. 22, doi. 10.1007/BF02710298
- By:
- Publication type:
- Article
High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial.
- Published in:
- Clinical & Translational Oncology, 2003, v. 5, n. 3, p. 148, doi. 10.1007/BF02712849
- By:
- Publication type:
- Article
CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1477, doi. 10.3390/ijms22031477
- By:
- Publication type:
- Article
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 151, doi. 10.1007/s10549-023-07002-1
- By:
- Publication type:
- Article
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 115, doi. 10.1007/s10549-019-05296-8
- By:
- Publication type:
- Article
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 129, doi. 10.1007/s10549-018-05097-5
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.
- Published in:
- Revista Española de Quimioterapia, 2023, v. 36, n. 1, p. 1, doi. 10.37201/req/087.2022
- By:
- Publication type:
- Article
Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3717, doi. 10.3390/cancers12123717
- By:
- Publication type:
- Article
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 457, doi. 10.1007/s10549-013-2416-2
- By:
- Publication type:
- Article
Regional and seasonal influence in patient's toxicity to adjuvant chemotherapy for early breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
Adjuvant chemotherapy in young women with breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- Report
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 1, p. 149, doi. 10.1007/s10549-009-0663-z
- By:
- Publication type:
- Article
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 169, doi. 10.1007/s10549-010-0860-9
- By:
- Publication type:
- Article
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0184181
- By:
- Publication type:
- Article